

LY2228820
- русский язык имя
- английское имяLY2228820
- CAS №862507-23-1
- CBNumberCB82518277
- ФормулаC26H37FN6O6S2
- мольный вес612.7369832
- номер MDLMFCD22572532
- файл Mol862507-23-1.mol
химическое свойство
температура хранения | Store at -20°C |
растворимость | ≥30.65 mg/mL in DMSO; ≥45 mg/mL in H2O with ultrasonic; ≥9.9 mg/mL in EtOH with ultrasonic |
форма | solid |
цвет | White to yellow |
FDA UNII | QUW7B71FO9 |
LY2228820 химические свойства, назначение, производство
Использование
LY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events.LY2228820 поставщик
поставщик | телефон | страна | номенклатура продукции | благоприятные условия |
---|---|---|---|---|
+86-(0)57185586718 +86-13336195806 |
China | 29792 | 60 | |
+undefined-21-51877795 | China | 32965 | 60 | |
86-13657291602 | CHINA | 22963 | 58 | |
+1-631-485-4226 | United States | 19553 | 58 | |
+86-0371-86658258 +8613203830695 |
China | 29809 | 58 | |
+1-781-999-5354 +1-00000000000 |
United States | 32161 | 58 | |
+86-29-89586680 +86-15129568250 |
China | 22787 | 58 | |
+1-2135480471 +1-2135480471 |
China | 10473 | 58 | |
+1-708-310-1919 +1-13798911105 |
United States | 6391 | 58 | |
United States | 38631 | 58 |